Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results
- PMID: 40253505
- PMCID: PMC12209408
- DOI: 10.1038/s41433-025-03805-2
Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results
Abstract
Purpose: To evaluate the effects of photobiomodulation (PBM) on choriocapillaris (CC) perfusion and drusen volume in patients with intermediate age-related macular degeneration (AMD).
Methods: In this retrospective pilot study, 30 patients receiving PBM therapy and 30 age-matched controls were analysed. Treatment consisted of 8 sessions over 4 weeks using the EYE-LIGHT® device. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), mean drusen volume (MDV), and CC flow deficit percentage (FD%) were evaluated at baseline and 2-month follow-up.
Results: The PBM group showed significant improvements in BCVA (Δ +3.2 ± 1.4 letters, p = 0.042), reduction in drusen volume (Δ -0.003 ± 0.001 mm³, p = 0.028), and decrease in choriocapillaris FD% (Δ -3.1 ± 1.4%, p = 0.024), while no significant changes were observed in the control group. Changes in choriocapillaris FD% correlated with BCVA improvement (r = -0.54, p = 0.002) and drusen volume reduction (r = 0.35, p = 0.042).
Conclusions: PBM therapy induces significant choriocapillaris remodelling in intermediate AMD, associated with functional improvement and drusen volume reduction. These findings suggest a potential therapeutic role of PBM in modulating choroidal perfusion in AMD.
© 2025. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
Conflict of interest statement
Competing interests: EB is a member of the Eye editorial board. The other authors declare no competing interests.
References
-
- Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1221–34. Available at: https://pubmed.ncbi.nlm.nih.gov/29032195/ [Accessed March 12, 2021]. - PubMed
-
- Milton RC, Clemons TE, Klien R, Seddon JM, Ferris FL. Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19. Ophthalmology. 2005;112:533–9.e1. Available at: https://pubmed.ncbi.nlm.nih.gov/15808240/ [Accessed November 14, 2022]. - PMC - PubMed
-
- Viggiano P, Toto L, Ferro G, Evangelista F, Porreca A, Mastropasqua R. Choroidal structural changes in different intermediate AMD patterns. Eur J Ophthalmol. 2021. Available at: [https://pubmed.ncbi.nlm.nih.gov/33506710/ Accessed March 25, 2021] - PubMed
-
- Voichanski S, Bousquet E, Abraham N, Santina A, Mafi M, Fossataro C, et al. En face optical coherence tomography illustrates the trizonal distribution of Drusen and subretinal drusenoid deposits in the macula. Am J Ophthalmol. 2024;261:187–98. Available at: https://pubmed.ncbi.nlm.nih.gov/38218515/ [Accessed October 14, 2024]. - PubMed
-
- Curcio CA, Presley JB, Millican CL, Medeiros NE. Basal deposits and drusen in eyes with age-related maculopathy: Evidence for solid lipid particles. Exp Eye Res. 2005;80:761–75. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical